Robert Bermel

5.1k total citations
84 papers, 2.7k citations indexed

About

Robert Bermel is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Robert Bermel has authored 84 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pathology and Forensic Medicine, 20 papers in Rheumatology and 13 papers in Neurology. Recurrent topics in Robert Bermel's work include Multiple Sclerosis Research Studies (65 papers), Rheumatoid Arthritis Research and Therapies (13 papers) and Systemic Lupus Erythematosus Research (11 papers). Robert Bermel is often cited by papers focused on Multiple Sclerosis Research Studies (65 papers), Rheumatoid Arthritis Research and Therapies (13 papers) and Systemic Lupus Erythematosus Research (11 papers). Robert Bermel collaborates with scholars based in United States, Switzerland and Germany. Robert Bermel's co-authors include Rohit Bakshi, Christopher W. Tjoa, Richard A. Rudick, Srinivas R. Puli, Lawrence Jacobs, Jeffrey A. Cohen, Ralph H. B. Benedict, Robert J. Fox, Elizabeth Fisher and Daniel Ontaneda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Robert Bermel

81 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Bermel United States	30	1.9k	617	519	508	483	84	2.7k
Paola Perini Italy	22	1.8k 0.9×	769 1.2×	532 1.0×	423 0.8×	314 0.7×	68	2.4k
Dejan Jakimovski United States	29	2.1k 1.1×	764 1.2×	511 1.0×	324 0.6×	472 1.0×	179	3.0k
Darin T. Okuda United States	24	2.7k 1.4×	1.1k 1.8×	650 1.3×	589 1.2×	484 1.0×	113	3.4k
Carmen Tur Spain	31	2.7k 1.4×	1.2k 2.0×	751 1.4×	682 1.3×	387 0.8×	109	3.6k
Deepa P. Ramasamy United States	34	2.1k 1.1×	938 1.5×	562 1.1×	622 1.2×	322 0.7×	107	3.0k
Šarlota Mesaroš Serbia	28	1.8k 0.9×	622 1.0×	444 0.9×	520 1.0×	303 0.6×	95	2.4k
Maria Laura Stromillo Italy	25	1.7k 0.9×	780 1.3×	546 1.1×	456 0.9×	330 0.7×	65	2.3k
Luca Massacesi Italy	33	1.7k 0.9×	648 1.1×	552 1.1×	225 0.4×	730 1.5×	123	3.3k
Daniel Ontaneda United States	30	1.9k 1.0×	717 1.2×	441 0.8×	289 0.6×	448 0.9×	144	2.6k
Ángela Vidal‐Jordana Spain	22	1.7k 0.9×	630 1.0×	473 0.9×	167 0.3×	358 0.7×	76	2.3k

Countries citing papers authored by Robert Bermel

Since Specialization

Citations

This map shows the geographic impact of Robert Bermel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bermel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bermel more than expected).

Fields of papers citing papers by Robert Bermel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bermel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bermel. The network helps show where Robert Bermel may publish in the future.

Co-authorship network of co-authors of Robert Bermel

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bermel. A scholar is included among the top collaborators of Robert Bermel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bermel. Robert Bermel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kunchok, Amy, Moein Amin, Robert Bermel, et al.. (2025). Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD , MS and Healthy Controls, and Disability Associations. Annals of Neurology. 98(5). 1044–1056.

Abbatemarco, Justin, Daniel Ontaneda, Mary Rensel, et al.. (2023). Race and Social Determinants of Health in Performance Outcomes among Relapsing Remitting Multiple Sclerosis Patients (P13-3.017). Neurology. 100(17_supplement_2). 1 indexed citations

Wiendl, Heinz, Laura Airas, Tanuja Chitnis, et al.. (2023). Phase 3 REMODEL I/II Trials: Efficacy, Safety, and Tolerability of Remibrutinib in Patients with Relapsing Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 80. 105315–105315. 1 indexed citations

Graves, Jennifer, Frederike Cosima Oertel, Anneke van der Walt, et al.. (2021). Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders. Neurology Neuroimmunology & Neuroinflammation. 9(2). 32 indexed citations

Abbatemarco, Justin, J. Ted Hartman, Marisa McGinley, et al.. (2021). Providing Person-Centered Care via Telemedicine in the Era of COVID-19 in Multiple Sclerosis. SHILAP Revista de lepidopterología. 8. 3930602978–3930602978. 11 indexed citations

McGinley, Marisa, Daniel Ontaneda, Malory Weber, et al.. (2020). Teleneurology as a Solution for Outpatient Care During the COVID-19 Pandemic. Telemedicine Journal and e-Health. 26(12). 1537–1539. 37 indexed citations

Lee, Jonathan, Robert Bermel, Jennifer Bullen, Paul Ruggieri, & Stephen E. Jones. (2020). Structured Reporting in Multiple Sclerosis Reduces Interpretation Time. Academic Radiology. 28(12). 1733–1738. 6 indexed citations

Uchida, Atsuro, Jagan A. Pillai, Robert Bermel, et al.. (2020). Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases. PLoS ONE. 15(9). e0237078–e0237078. 18 indexed citations

Fox, Robert J., Matthew Karafa, Christian Barro, et al.. (2019). Effect of Ibudilast on Neurofilament-light Chain in Progressive MS: Analysis from a Phase II Trial (P3.2-033). Neurology. 92(15_supplement). 4 indexed citations

10.

Ontaneda, Daniel, Kavita Nair, Robert Bermel, et al.. (2019). Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up. Journal of the Neurological Sciences. 407. 116498–116498. 15 indexed citations

11.

Baldassari, Laura, Kunio Nakamura, Brandon Moss, et al.. (2019). Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice. Multiple Sclerosis and Related Disorders. 38. 101525–101525. 15 indexed citations

12.

Rao, Stephen M., Lyla Mourany, David Schindler, et al.. (2017). Processing speed test: Validation of a self-administered, iPad ^® -based tool for screening cognitive dysfunction in a clinic setting. Multiple Sclerosis Journal. 23(14). 1929–1937. 117 indexed citations

13.

Gunzler, Douglas, Nathan Morris, Adam T. Perzynski, et al.. (2016). Heterogeneous depression trajectories in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 9. 163–169. 17 indexed citations

14.

Lowe, Mark J., Katherine Koenig, Erik B. Beall, et al.. (2014). Anatomic Connectivity Assessed Using Pathway Radial Diffusivity Is Related to Functional Connectivity in Monosynaptic Pathways. Brain Connectivity. 4(7). 558–565. 14 indexed citations

15.

Bermel, Robert, et al.. (2014). Early Tolerability Of Dimethyl Fumarate For Treatment Of Multiple Sclerosis (P2.214). Neurology. 82(10_supplement). 1 indexed citations

16.

Ontaneda, Daniel, Claire Hara-Cleaver, Richard A. Rudick, Jeffrey A. Cohen, & Robert Bermel. (2012). Early tolerability and safety of fingolimod in clinical practice. Journal of the Neurological Sciences. 323(1-2). 167–172. 41 indexed citations

17.

Bermel, Robert, Elizabeth Fisher, & Jeffrey A. Cohen. (2008). The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials. Neuroimaging Clinics of North America. 18(4). 687–701. 12 indexed citations

18.

Bermel, Robert, Srinivas R. Puli, Richard A. Rudick, et al.. (2005). Prediction of Longitudinal Brain Atrophy in Multiple Sclerosis by Gray Matter Magnetic Resonance Imaging T2 Hypointensity. Archives of Neurology. 62(9). 1371–1371. 82 indexed citations

19.

Bermel, Robert, Jitendra Sharma, Christopher W. Tjoa, Srinivas R. Puli, & Rohit Bakshi. (2003). A semiautomated measure of whole-brain atrophy in multiple sclerosis. Journal of the Neurological Sciences. 208(1-2). 57–65. 98 indexed citations

20.

Bermel, Robert, Rohit Bakshi, Christopher W. Tjoa, Srinivas R. Puli, & Lawrence Jacobs. (2002). Bicaudate Ratio as a Magnetic Resonance Imaging Marker of Brain Atrophy in Multiple Sclerosis. Archives of Neurology. 59(2). 275–275. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact